Low-dose acetylsalicylic acid

Aspirin at doses of 75-100 mg daily used as a cardiovascular antiplatelet agent. It blocks the synthesis of arachidonic acid-derived prostaglandins in platelets and endothelium, hindering platelet aggregation. In Spain it is marketed as Adiro (gastro-resistant tablets of 100 and 300 mg) and A.A.S. 100 mg, both authorised by the AEMPS.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.